The details of the collapse of AMLo Biosciences into administration last month have been revealed. ...
Oxford-based OrganOx has been sold in a mammoth £1.1bn deal. The company’s pioneering liver pe...
The impressive turnaround at Inspiration Healthcare Group plc is continuing following major changes ...
The founder and CEO of FTSE 250 constituent Oxford Nanopore Technologies has revealed that he will s...
In a post-pandemic world, international healthcare has entered a new era. Medical tourism is no long...
London-based startup Sava Technologies has raised £14.2m in Series A funding following promising ea...
MedTech Centauri Therapeutics has received an extra £3.8m in funding from CARB-X to develop its lea...
Listed MedTech Avacta Therapeutics has sold Coris Bioconcept SRL to 3B BlackBio Dx for an upfront fe...
A London-based MedTech developing vaccines against life threatening respiratory viral infections has...
FTSE 250 constituent Oxford Nanopore Technologies plc has released positive results for the first ha...
A Surrey-based listed MedTech has undergone a leadership shake up after its CEO and chairman both ag...
The entrepreneur behind the £100m exit of OXGENE in 2021 has secured funding for his next venture. ...